Article 19 May 2025 President Trump Issues Two Executive Orders Concerning The Affordability And Accessibility Of Drugs United States Healthcare
Article 14 May 2025 Most Favored Nation Drug Pricing Executive Order Resurrects Prior President Trump Policy United States Healthcare
Article 04 Apr 2025 A Look Ahead In Life Sciences: What We Are Tracking In The Second Quarter Of 2025 And Beyond Worldwide Healthcare
Article 03 Mar 2025 OIG Issues Two Favorable Advisory Opinions For Dental Supply Loyalty Program And Pharmaceutical Manufacturer Sponsor Of Genetic Tests United States Healthcare
Article 28 Feb 2025 Goodwin's 2025 Rare Disease Symposium: Momentum Builds For Addressing Critical Diagnosis And Treatment Gaps United States Healthcare
Article 24 Feb 2025 First Circuit Adopts Defense-Friendly "But-For" Causation Standard For AKS-Predicated FCA Claims United States Healthcare
Article 27 Jan 2025 How The Trump Administration Could Reshape Regulation In The Life Sciences Sector United States Healthcare
Article 10 Jan 2025 Changes Expected As Trump Administration Continues To Take Shape United States Compliance
Article 07 Nov 2024 New Momentum For A Time-Limited Conditional Approval Pathway For Rare Disease Drugs United States Healthcare